Insider Selling: ReposiTrak (NYSE:TRAK) CEO Sells 4,000 Shares of Stock

ReposiTrak Inc. (NYSE:TRAK) CEO Randall Fields sold 4,000 shares of the stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $8.06, for a total transaction of $32,240.00. Following the completion of the transaction, the chief executive officer owned 85,000 shares of the company’s stock, valued at approximately $685,100. This represents a 4.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

ReposiTrak Price Performance

Shares of ReposiTrak stock traded up $0.12 during trading on Monday, hitting $8.03. 98,806 shares of the company’s stock traded hands, compared to its average volume of 113,032. The firm’s fifty day moving average price is $10.05 and its 200 day moving average price is $13.14. ReposiTrak Inc. has a twelve month low of $7.80 and a twelve month high of $23.72. The company has a market cap of $146.15 million, a PE ratio of 21.70 and a beta of 0.49.

ReposiTrak (NYSE:TRAK) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.09 earnings per share (EPS) for the quarter. The firm had revenue of $5.86 million during the quarter. ReposiTrak had a net margin of 30.62% and a return on equity of 14.52%.

Analyst Ratings Changes

Several equities analysts recently commented on TRAK shares. Weiss Ratings restated a “hold (c+)” rating on shares of ReposiTrak in a research report on Monday, December 29th. Wall Street Zen cut ReposiTrak from a “buy” rating to a “hold” rating in a research report on Saturday, January 17th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Hedge Funds Weigh In On ReposiTrak

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. XTX Topco Ltd bought a new stake in ReposiTrak during the fourth quarter worth about $214,000. Occudo Quantitative Strategies LP bought a new position in shares of ReposiTrak in the fourth quarter valued at approximately $147,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of ReposiTrak by 23.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 28,094 shares of the company’s stock worth $348,000 after acquiring an additional 5,400 shares in the last quarter. Rice Hall James & Associates LLC boosted its holdings in shares of ReposiTrak by 6.4% in the 4th quarter. Rice Hall James & Associates LLC now owns 793,858 shares of the company’s stock worth $9,820,000 after acquiring an additional 47,914 shares in the last quarter. Finally, Squarepoint Ops LLC grew its position in ReposiTrak by 39.5% during the 4th quarter. Squarepoint Ops LLC now owns 99,830 shares of the company’s stock worth $1,235,000 after acquiring an additional 28,282 shares during the last quarter. 27.35% of the stock is currently owned by institutional investors and hedge funds.

ReposiTrak Company Profile

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.